+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Estrogen Receptor"

From
From
From
From
From
From
Osteoporosis Drugs Market Report 2025 - Product Thumbnail Image

Osteoporosis Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Osteoporosis Treatment Market Report 2025 - Product Thumbnail Image

Osteoporosis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Raloxifene Hydrochloride - Global Strategic Business Report - Product Thumbnail Image

Raloxifene Hydrochloride - Global Strategic Business Report

  • Report
  • July 2025
  • 177 Pages
  • Global
From
Osteoporosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Osteoporosis Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 340 Pages
  • Global
From
Postmenopausal Osteoporosis Treatment Market Report 2025 - Product Thumbnail Image

Postmenopausal Osteoporosis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Drugs for Hormonal Replacement Therapy Market Report 2025 - Product Thumbnail Image

Drugs for Hormonal Replacement Therapy Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
From
From
From
Central Precocious Puberty - Pipeline Insight, 2025 - Product Thumbnail Image

Central Precocious Puberty - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Postmenopausal Osteoporosis - Pipeline Insight, 2025 - Product Thumbnail Image

Postmenopausal Osteoporosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Osteoporosis Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Osteoporosis Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Loading Indicator

The Estrogen Receptor (ER) market is a segment of the Endocrine and Metabolic Disorders Drugs market. ER drugs are used to treat a variety of conditions, including menopausal symptoms, osteoporosis, and breast cancer. ER drugs work by binding to the estrogen receptor, which is found in many tissues throughout the body. This binding triggers a cascade of events that can lead to the desired therapeutic effect. ER drugs are typically administered orally, as a topical cream, or as an injection. ER drugs are typically prescribed to postmenopausal women, as well as to men with certain conditions. The market for ER drugs is expected to grow in the coming years, driven by an aging population and increasing awareness of the importance of hormone therapy. Some companies in the ER market include Pfizer, Novartis, Merck, and AstraZeneca. Show Less Read more